Construct: ORF ccsbBroadEn_05828
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF009113.1_s300c1, BRDN0000388487
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- AOAH (313)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 313 | AOAH | acyloxyacyl hydrolase | NM_001637.4 | 99.9% | 100% | 66G>A |
| 2 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_017012102.2 | 95.5% | 95.4% | 66G>A;1057_1058ins75 |
| 3 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515336.2 | 95% | 93.4% | (many diffs) |
| 4 | human | 313 | AOAH | acyloxyacyl hydrolase | NM_001177507.1 | 94.3% | 94.4% | 66G>A;126_127ins96 |
| 5 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515338.2 | 92.7% | 92.6% | (many diffs) |
| 6 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_017012104.1 | 88.4% | 88.1% | (many diffs) |
| 7 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515339.2 | 88.4% | 88.8% | (many diffs) |
| 8 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515340.2 | 88.2% | 88.1% | 66G>A;1522_1523insTCATAC;1524_1525ins195 |
| 9 | human | 313 | AOAH | acyloxyacyl hydrolase | NM_001177506.1 | 83.5% | 77% | 66G>A;1600_1718del;1845_2064del |
| 10 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515333.2 | 79.8% | 73.3% | (many diffs) |
| 11 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515334.2 | 78.8% | 72.5% | (many diffs) |
| 12 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515335.2 | 77.5% | 70.9% | (many diffs) |
| 13 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_017012106.1 | 76.2% | 75.8% | (many diffs) |
| 14 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515341.2 | 75.9% | 75.6% | (many diffs) |
| 15 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_017012105.1 | 47.5% | 38.7% | (many diffs) |
| 16 | human | 313 | AOAH | acyloxyacyl hydrolase | XM_011515342.2 | 42.9% | 37% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1791
- ORF length:
- 1725
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGCA GTCCCCCTGG AAAATCCTTA CGGTGGCGCC TCTATTCTTG CTCCTGTCTC 121 TTCAGTCCTC AGCCTCTCCA GCCAACGATG ACCAGTCCAG GCCCAGCCTC TCGAATGGGC 181 ACACCTGTGT AGGGTGTGTG CTGGTGGTGT CTGTAATAGA ACAGCTTGCT CAAGTTCACA 241 ACTCGACGGT CCAGGCCTCG ATGGAGAGAC TGTGCAGCTA CCTGCCTGAA AAACTGTTCT 301 TGAAAACCAC CTGCTATTTA GTCATTGACA AGTTTGGATC AGACATCATA AAACTGCTTA 361 GCGCAGATAT GAATGCTGAT GTGGTATGTC ACACTCTGGA GTTTTGTAAA CAGAACACTG 421 GCCAACCATT GTGTCATCTC TACCCTCTTC CCAAGGAGAC ATGGAAATTT ACACTACAGA 481 AGGCAAGACA AATTGTCAAG AAGTCCCCGA TTCTGAAATA TTCTAGAAGT GGTTCTGACA 541 TTTGTTCACT CCCGGTTTTG GCCAAGATCT GCCAGAAAAT TAAATTAGCT ATGGAACAGT 601 CTGTGCCATT CAAAGATGTG GATTCAGACA AATACAGCGT TTTCCCAACA CTGCGGGGCT 661 ATCACTGGCG GGGGAGAGAC TGTAATGACA GCGACGAGTC AGTGTACCCA GGTAGAAGGC 721 CGAACAACTG GGATGTCCAT CAGGATTCAA ACTGTAATGG CATTTGGGGT GTCGATCCAA 781 AAGATGGAGT TCCATATGAG AAGAAATTCT GTGAAGGTTC ACAGCCCAGG GGAATCATTT 841 TGCTGGGAGA CTCAGCTGGG GCTCATTTTC ACATCTCTCC TGAATGGATC ACAGCGTCGC 901 AGATGTCTTT GAACTCTTTC ATCAATCTAC CAACAGCCCT TACCAACGAG CTTGACTGGC 961 CCCAACTCTC TGGTGCTACA GGATTTCTGG ACTCCACTGT TGGAATTAAA GAAAAATCTA 1021 TTTACCTTCG CTTATGGAAA AGAAACCACT GTAATCACAG GGACTACCAG AATATTTCAA 1081 GAAATGGTGC ATCTTCCCGA AACCTGAAGA AATTTATAGA AAGCTTGTCT AGAAACAAGG 1141 TGTTGGACTA TCCCGCCATC GTTATATATG CCATGATTGG AAATGATGTC TGCAGTGGGA 1201 AGAGTGACCC AGTCCCAGCC ATGACCACTC CTGAGAAACT CTACTCCAAC GTCATGCAGA 1261 CTCTGAAGCA TCTAAATTCC CACCTGCCCA ATGGCAGCCA TGTTATTTTG TATGGCTTAC 1321 CAGATGGAAC CTTTCTCTGG GATAATTTGC ACAACAGATA TCATCCTCTC GGCCAGCTAA 1381 ATAAAGACAT GACCTATGCG CAGTTGTACT CCTTCCTGAA CTGCCTCCAG GTCAGCCCCT 1441 GCCACGGCTG GATGTCTTCC AACAAGACGT TGCGGACTCT CACTTCAGAG AGAGCAGAGC 1501 AACTCTCCAA CACACTGAAA AAAATTGCAG CCAGTGAGAA ATTTACAAAC TTCAATCTTT 1561 TCTACATGGA TTTTGCCTTC CATGAAATCA TACAGGAGTG GCAGAAGAGA GGCGGACAGC 1621 CCTGGCAGCT CATCGAGCCC GTGGATGGAT TCCACCCCAA CGAGGTGGCT TTGCTGTTGT 1681 TGGCGGATCA TTTCTGGAAA AAGGTGCAGC TCCAGTGGCC CCAAATCCTG GGAAAGGAGA 1741 ATCCGTTCAA CCCCCAGATT AAACAGGTGT TTGGAGACCA AGGCGGGCAC TGCCCAACTT 1801 TCTTGTACAA AGTtggcatt ataagaaagc attgcttatc aatttgttgc aacgaac